Clinical Trial

Feasibility Performance Study of ABL90 FLEX PLUS HEM

Study acronym: ABL90FLEXHEM
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 15, 2026 (before its estimated May 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
This feasibility performance study evaluates the ABL90 FLEX PLUS HEM device for its analytical performance in a clinical setting. The study aims to evaluate the performance of the hemolysis detection feature.
Trial Details
NCT Number NCT07345091
Lead Sponsor Radiometer Medical ApS
Collaborators: Bispebjerg Hospital
Conditions Hemolysis
Enrollment 95 participants
Start Date 2025-08-04
Primary Completion 2026-05-10 (estimated)
Study Completion 2026-06-10 (estimated)
Updated on ClinicalTrials.gov 2026-01-15